Renin-angiotensin system blockade on angiotensin-converting enzyme 2 and TMPRSS2 in human type II pneumocytes-Reference-Cited by-同舟云学术

Renin-angiotensin system blockade on angiotensin-converting enzyme 2 and TMPRSS2 in human type II pneumocytes

Published:2022-03 Issue: Volume:293 Page:120324
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Silva Mauro G.,Falcoff Nora L.,Corradi Gerardo R.,Alfie José,Seguel Rolando F.,Tabaj Gabriela C.,Iglesias Laura I.,Nuñez Myriam,Guman Gabriela R.,Gironacci Mariela M.

Funder

Agencia Nacional De Promocion Cientifica Y Tecnologica

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference61 articles.

1. The ACE2/Angiotensin-(1–7)/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1–7);Santos;Physiol. Rev.,2018

2. Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology;Forrester;Physiol. Rev.,2018

3. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2;Gheblawi;Circ. Res.,2020

4. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection;Zou;Front. Med.,2020

5. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor;Hoffmann;Cell,2020

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum Angiotensin II as a Biomarker in COVID-19;Biomarkers in Trauma, Injury and Critical Care;2023

2. Angiotensin and COVID-19;Angiotensin;2023

3. Morphological aspect of the angiotensin-converting enzyme 2;Angiotensin;2023

4. Genetic Deletion of Galectin-3 Exacerbates Age-Related Myocardial Hypertrophy and Fibrosis in Mice;Cellular Physiology and Biochemistry;2022-08-12

5. Plasmatic renin-angiotensin system in normotensive and hypertensive patients hospitalized with COVID-19;Biomedicine & Pharmacotherapy;2022-08